Llewellyn King on the unfolding drama of FDA’s Dec 20 Ampligen hearing

After much suffering, the biblical character Lazarus was raised from the dead. Will the FDA look favorably on the ‘Lazarus’ drug Ampligen after its ME/CFS patient hearing on Thursday, Dec 20?

The live online hearing will feature public testimony from ME/CFS patients who believe use of this potent experimental drug has helped them. For a concise description of the stakes & uncertainties involved, see “FDA to rule on ‘Lazarus’ drug,” published Dec 15 by ME/CFS Alert co-host Llewellyn King at StamfordAdvocate.com.

1 Star2 Stars3 Stars4 Stars5 Stars (7 votes, average: 5.00 out of 5)

Leave a Reply